Trial Profile
An Open-label, One-sequence Study to Assess the Effect of Repeated Oral Doses of Cimetidine on the Single Dose Pharmacokinetics, Safety and Tolerability of Imeglimin in Healthy Caucasian Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Sep 2020
Price :
$35
*
At a glance
- Drugs Imeglimin (Primary) ; Cimetidine
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Poxel
- 29 Aug 2020 Results published in the European Journal of Drug Metabolism and Pharmacokinetics
- 16 Aug 2018 New trial record